ActiPatch Electromagnetic Therapy Given FDA Premarket Notification in the U.S. for Musculoskeletal Pain
News
The U.S. Food and Drug Administration (FDA) has cleared BioElectronics Corporation’s premarket notification — also known as a 510(k) — for its ActiPatch medical device as an over-the-counter add-on therapy for any form of ... Read more